thiazolyl blue has been researched along with bufalin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, D; Guo, H; Qu, G; Ye, M | 1 |
| Cui, Y; Gong, Y; Kang, X; Lu, P; Wang, Y; Xu, Z; Zhang, Q | 1 |
2 other study(ies) available for thiazolyl blue and bufalin
| Article | Year |
|---|---|
Novel cytotoxic bufadienolides derived from bufalin by microbial hydroxylation and their structure-activity relationships.
Topics: Bacteria; Biological Assay; Bufanolides; Cell Line, Tumor; Chromatography, High Pressure Liquid; Coloring Agents; Enzyme Inhibitors; Fungi; HeLa Cells; HL-60 Cells; Humans; Magnetic Resonance Spectroscopy; Mass Spectrometry; Models, Chemical; Oxygen; Spectrophotometry; Structure-Activity Relationship; Tetrazolium Salts; Thiazoles; Ultraviolet Rays | 2004 |
[Bufalin reverses hepatocyte growth factor-induced resistance to afatinib in H1975 lung cancer cells].
Topics: Afatinib; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bufanolides; Cadherins; Cell Line, Tumor; Cell Proliferation; Coloring Agents; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; ErbB Receptors; Hepatocyte Growth Factor; Humans; Lung Neoplasms; MAP Kinase Signaling System; Neoplasm Proteins; Phosphatidylinositol 3-Kinases; Quinazolines; Signal Transduction; Tetrazolium Salts; Thiazoles | 2015 |